DARE (Dare Bioscience) 50-Day SMA: $2.27 (As of Jul. 08, 2026)


DARE Dare Bioscience Inc DARE
21 GF Score
Price $2.04
! 4 Warning Signs
View Full Analysis

What is Dare Bioscience 50-Day SMA?

Dare Bioscience DARE -1.44% 21 50-Day SMA is $2.27 as of Jul. 08, 2026. GuruFocus rates DARE with a GF Score™ of 21/100. The stock has 4 warning signs investors should review.

Moving averages are one of the core indicators in technical analysis. A Simple Moving Average (SMA) is simply the arithmetic average of stock price over a period. It is calculated by adding a selected range of prices, usually closing prices, and then dividing that figure by the number of time periods in that range.

The 50-Day SMA calculates the average price over 50 days. And the 20-Day SMA and 200-Day SMA calculates the average price over 20 days and 200 days separately.

As of today (2026-07-08), Dare Bioscience's 50-Day SMA is $2.27. It's 20-Day SMA is $2.05 and 200-Day SMA is $1.99.

Dare Bioscience  (NAS:DARE) 50-Day SMA Explanation

Simple Moving Average (SMA) is the arithmetic average of stock price over a period. The 20-Day SMA calculates the average price over 20 days. And the 50-Day SMA and 200-Day SMA calculates the average price over 50 days and 200 days separately. SMAs are often used to determine the price trend direction. A 200-Day SMA is usually a proxy for the long-term trend, while shorter periods indicate short-term trend.

SMA are commonly compared with stock price or different period SMAs to indicate a trading signal. Generally speaking, if the price goes above the SMA, or a short-term SMA crosses above a long-term SMA, an uptrend is expected, investors may want to go long or cover short. Conversely, if the price goes below the SMA, or the short-term SMA crosses below a long-term SMA, a downtrend is expected, investors may want to go short or exit long.

Two popular trading patterns that use SMA include the death cross and a golden cross. A death cross occurs when the 50-day SMA crosses below the 200-day SMA. This is considered a bearish signal, that further losses are in store. The golden cross is a bullish signal which occurs when a short-term SMA crosses above a long-term SMA.

Dare Bioscience 50-Day SMA Related Terms

DARE vs ATNM, NNVC, LSTA: 50-Day SMA Comparison

For the Biotechnology subindustry, Dare Bioscience's 50-Day SMA, along with its competitors' market caps and 50-Day SMA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Dare Bioscience 50-Day SMA vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Dare Bioscience's 50-Day SMA distribution charts can be found below:

* The bar in red indicates where Dare Bioscience's 50-Day SMA falls into.


DARE
21GF Score
Dare Bioscience Inc DARE
50-Day SMA is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Dare Bioscience  (NAS:DARE) 50-Day SMA Calculation

The formula for calculating SMA is:

SMA=( P1 + P2 + ... + Pn ) / n

where:
Pn is the price of the stock at period n.
n is the total number of periods.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about 50-Day SMA →
What does a 50-Day SMA of $2.27 mean?
Dare Bioscience (DARE) has a 50-Day SMA of $2.27 as of Jul. 08, 2026. Simple Moving Average (SMA) is the arithmetic average of stock price over a period. View historical data on Dare Bioscience and its competitors.
Is Dare Bioscience's 50-Day SMA too high?
Dare Bioscience's current 50-Day SMA is $2.27. Overall, Dare Bioscience has a GF Score™ of 21/100, reflecting its overall financial health beyond just this single metric.
How does Dare Bioscience's 50-Day SMA compare to ATNM and NNVC?
Dare Bioscience's 50-Day SMA of $2.27 can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 50-Day SMA for a Biotechnology company?
A good 50-Day SMA depends on the Biotechnology industry context. However, 50-Day SMA should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 50-Day SMA mean?
A high 50-Day SMA can signal that a stock is expensive relative to its fundamentals. Simple Moving Average (SMA) is the arithmetic average of stock price over a period. View historical data on Dare Bioscience and its competitors. Dare Bioscience's current 50-Day SMA is $2.27. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Dare Bioscience stock overvalued right now?
Dare Bioscience (DARE) has a current 50-Day SMA of $2.27. The current 50-Day SMA is $2.27. Dare Bioscience's overall GF Score™ is 21/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 50-Day SMA calculated?
50-Day SMA is calculated from a company's financial statements. For Dare Bioscience (DARE), the current 50-Day SMA is $2.27 as of Jul. 08, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Dare Bioscience Business Description

Address 3655 Nobel Drive, Suite 260, San Diego, CA, USA, 92122
Dare Bioscience Inc is a biopharmaceutical company committed to advancing products for women's health. The company identifies, develops, and brings to market a diverse portfolio of differentiated therapies that prioritize women's health and well-being, expand treatment options, and improve outcomes, in the areas of contraception, fertility, and vaginal and sexual health. The company's first product, XACIATO is a single-dose vaginal gel prescription product for the treatment of bacterial vaginosis in females 12 years of age and older. The company's portfolio includes two product candidates in clinical development namely, Ovaprene and Sildenafil Cream. It has one operating segment, women's health.
21GF Score

Get the complete analysis for DARE

50-Day SMA is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$2.04
Price